I>LINKERS FOR SPPS (Click to order)
- Wang linker
Cas#: 623-05-2
Cat#: 8511001
- HMPB linker
Cas#: 136849-75-7
Cat#: 8511004
Cas#: 3006-96-0
Cat#: 8511003
Cas#: 212783-75-0
Cat#: 8511029
Cas#: 3722-51-8
Cat#: 8511032
Cas#:--
Cat#: 8511027
Cas#: 18278-34-7
Cat#: 8511047
Cas#: 145069-56-3
Cat#: 8511005
Cas#: 115109-65-4
Cat#: 8511009
Cas#: -
Cat#: 8511033
- HMP linker
Cas#:68858-21-9
Cat#: 8511002
Cas#: 73401-74-8
Cat#: 8511048
Cas#: 41351-30-8
Cat#: 8511052
Cas#: 22080-96-2
Cat#: 8511053
For industrial demand (multi-kilos) please contact us directly via: order@psyclopeptide.com , or call +86-21-6718 1678
II>Research Peptides
Somatostatin analogs
- 1. Somatostatin
Cas#: 38916-34-6
Cat#: 1225002
Sequence: Ala-Gly-cyclo[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys]
- 2. Octreotide
Cas#: 83150-76-9
Cat#: 1225003
Sequence: D-Phe-cyclo[Cys-Phe-D-Trp-Lys-Thr-Cys]-L-threoninol
- 3. DOTA-tyr3-Octreotide(DOTA-TOC)
Cas#: 204318-14-9
Cat#: 1225007
Sequence: DOTA-D-Phe-cyclo[Cys-Tyr-D-Trp-Lys-Thr-Cys]-L-threoninol
- 4. DOTA-TATE
Cas#: --
Cat#: 1225013
Sequence: DOTA-D-Phe-cyclo[Cys-Tyr-D-Trp-Lys-Thr-Cys]-Thr
- 5. Depreotide
Cas#: 161982-62-3
Cat#: 1225016
Sequence: Lys-Cys-Lys-(beta-DAP)-CH2CO-S-cyclo(hCys-(N-Me)Phe-Tyr-D-Trp-Lys-Val)
- 6. Lanreotide
Cas#: 108736-35-2
Cat#: 1225004
Sequence: D-2-Nal-cyclo[Cys-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2
- 7. Pasireotide
Cas#: 396091-73-9
Cat#: 1225005
Sequence:
Cyclo[Hyp(2-aminoethyl-carbamoyl)-Phg-D-Trp-Lys-Tyr(Bzl)-Phe]
Growth hormone-releasing hormone & secretagogues
- 15. Sermorelin
Cas#: 86168-78-7
Cat#: 1223002
Sequence:
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
- 16. Tesamorelin
Cas#: 901758-09-6
Cat#: 1223010
Sequence:
N-[(3E)-hex-3-enoyl]-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg--Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
- 17. GHRP-6
Cas#: 87616-84-0
Cat#: 1223003
Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
- 18. Hexarelin
Cas#: 140703-51-1
Cat#: 1223006
Sequence: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
- 19. Ipamorelin
Cas#: 170851-70-4
Cat#: 1223007
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Melanocyte stimulating hormone (MSH) analogs
- 25. Afamelanotide
Cas#: 64887-70-3
Cat#: 1284004
Sequence: Ac-Ser-Tyr-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
- 26. Melanotan II
Cas#: 121062-08-6
Cat#: 1284005
Sequence: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-NH2
- 27. Bremelanotide
Cas#: 189691-06-3
Cat#: 1284006
Sequence: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH
Gonadotropin-releasing hormone (GnRH) agonist & antagonists
- 8. Leuprolide
Cas#: 74381-53-6
Cat#: 1224005
Sequence: Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
- 9. Triptorelin
Cas#: 57773-63-4
Cat#: 1224007
Sequence: Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
- 10. Nafarelin
Cas#: 76932-56-4
Cat#: 1224006
Sequence: Pyr-His-Trp-Ser-Tyr-2Nal-Leu-Arg-Pro-Gly-NH2
- 11. Buserelin
Cas#: 57982-77-1
Cat#: 1224002
Sequence: Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt
- 12. Goserelin
Cas#: 65807-02-5
Cat#: 1224003
Sequence: Pyr-His-Trp-Ser-Tyr-D-Ser(OtBu)-Leu-Arg-Pro-AzGly-NH2
- 13. Degarelix
Cas#: 214766-78-6
Cat#: 1224010
Sequence:
Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph(L-Hor)-D-4Aph(Cbm)-Leu-lIys-Pro-D-Ala-NH2
- 14. Abarelix
Cas#: 183552-38-7
Cat#: 1224008
Sequence:
Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-N(Me)Tyr-D-Asn-Leu-llys-Pro-D-Ala-NH2
Glucagon & Glucagon-like peptide-1 (GLP-1) analogs
- 20. Glucagon
Cas#: 19179-82-9
Cat#: 1207001
Sequence:
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr
Cas#: 107444-51-9
Cat#: 1208003
Sequence: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
- 22. Exendin-4
Cas#: 141758-74-9
Cat#: 1208007
Sequence:
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
- 23. Liraglutide
Cas#: 204656-20-2
Cat#: 1208004
Sequence:
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly
- 24. Teduglutide
Cas#: 287714-30-1
Cat#: 1209002
Sequence:
His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp
Materials for research purpose ONLY!
III>Fructo-oligose Monomer Standards
| Catalog# | CAS NO. | Abbreviation | Product name | M.W. | M.F. | CID | Reference |
| 7201008 | 470-69-9 | 1-Kestose | 1F-beta-D-Fructosylsucrose(GF2), Beta-D-fructofuranosyl-(2->1)-beta-D-fructofuranosyl alpha-D-glucopyranoside, DQR, Beta-D-Fruf-(2->1)-beta-D-Fruf-(2->1)-alpha-D-Glup, | C18H32O16 | 504.44 | 440080 | Crit Rev Food Sci Nutr. 2015;55(11):1475-90. Recent Pat Food Nutr Agric. 2009 Nov; 1(3):221-30. J Bacteriol. 1998 March; 180(5): 1305–1310. |
| The nutritional and therapeutic benefits of prebiotics have attracted the keen interest of consumers and food processing industry for their use as food ingredients. Fructo-oligosaccharides (FOS), new alternative sweeteners, constitute 1-kestose, nystose, and 1-beta-fructofuranosyl nystose produced from sucrose by the action of fructosyltransferase from plants, bacteria, yeast, and fungi. FOS has low caloric values, non-cariogenic properties, and help gut absorption of ions, decrease levels of lipids and cholesterol and bifidus-stimulating functionality. The purified linear fructose oligomers are added to various food products like cookies, yoghurt, infant milk products, desserts, and beverages due to their potential health benefits. Prebiotics are food ingredients that promote host health beneficially due to their effect over the growth and activity of probiotic bacterial species. Prebiotic properties have been demonstrated for inulin-type fructans, galactoolicosaccharides and lactulose. Fructooligosaccharides (FOS), considered as inulin-type fructans, represent an important source of prebiotic compounds that are widely used as an ingredient in functional foods. FOS are produced by the action of fructosyltransferase from many plants, fungi and bacteria, and they are mainly composed of 1-kestose, nystose, and 1-beta-fructofuranosyl nystose. Among them, 1-kestose has better therapeutic properties than those with a high polymeric degree (GF(n > 4)). FOS exhibited properties than those with a high polymeric degree (GF(n>4)). FOS exhibited properties such as low caloric values, non-cariogenic properties, decrease levels of lipids and cholesterol, help gut absorption of ions, and stimulate the bifidobacteria growth in the human colon. | |||||||
| 7201009 | 13133-07-8 | Nystose | Nystose (GF3), Fungitetraose, Nistose, Nystose trihydrate,1, 1-kestotetraose, | C24H42O21 | 666.58 | 166775 | Crit Rev Food Sci Nutr. 2015;55(11):1475-90. Int J Food Sci Nutr. 2012 May; 63(3):338-42. Arch Anim Nutr. 2005 Aug; 59(4):247-56. Carbohydr Res. 1993 Jul 5; 245(1):11-9. |
| The nutritional and therapeutic benefits of prebiotics have attracted the keen interest of consumers and food processing industry for their use as food ingredients. Fructo-oligosaccharides (FOS), new alternative sweeteners, constitute 1-kestose, nystose, and 1-beta-fructofuranosyl nystose produced from sucrose by the action of fructosyltransferase from plants, bacteria, yeast, and fungi. FOS has low caloric values, non-cariogenic properties, and help gut absorption of ions, decrease levels of lipids and cholesterol and bifidus-stimulating functionality. The purified linear fructose oligomers are added to various food products like cookies, yoghurt, infant milk products, desserts, and beverages due to their potential health benefits. | |||||||
| 7201010 | 59432-60-9 | 1F-fructofuranosylnystose | 1,1,1-kestopentaose, O-KPE, 1F-beta-Fructofranosylnystose, fructofuranosyl nystose (GF4),1F-β-fructofuranosylnystose, | C30H52O26 | 828.72 | 74539959 | J Ind Microbiol Biotechnol. 2014 Jun;41(6):893-906. |
| The industrial production of short-chain fructooligosaccharides (FOS) and inulooligosaccharides is expanding rapidly due to the pharmaceutical importance of these compounds. These compounds, concisely termed prebiotics, have biofunctional properties and hence health benefits if consumed in recommended dosages. Prebiotics can be produced enzymatically from sucrose elongation or via enzymatic hydrolysis of inulin by exoinulinases and endoinulinases acting alone or synergistically. Exoinulinases cleave the non-reducing β-(2, 1) end of inulin-releasing fructose while endoinulinases act on the internal linkages randomly to release inulotrioses (F3), inulotetraoses (F4) and inulopentaoses (F5) as major products. Fructosyltransferases act by cleaving a sucrose molecule and then transferring the liberated fructose molecule to an acceptor molecule such as sucrose or another oligosaccharide to elongate the short-chain fructooligosaccharide. The FOS produced by the action of fructosyltransferases are 1-kestose (GF2), nystose (GF3) and fructofuranosyl nystose (GF4). | |||||||
| 7201011 | GF5 | Fructo-oligosaccharide DP6, | C36H62O31 | 990.86 | |||
| 7201012 | GF6 | Fructo-oligosaccharide DP7, | C42H72O36 | 1153 | |||
Please inquire us : support@psyclopeptide.com
HPLC-ELSD REPORT SAMPLE
